Itacitinib in Advanced Hepatocellular Carcinoma

NCT04358185 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: Itacitinib

Sponsor

Imperial College London

Collaborators

[object Object]